The global stem cell patent landscape: implications for efficient technology transfer and commercial development
暂无分享,去创建一个
[1] Leonard Berkowitz,et al. Innovation and Its Discontents: How Our Broken Patent System Is Endangering Innovation and Progress and What to Do about It , 2005 .
[2] Robert P. Merges,et al. Contracting into Liability Rules: Intellectual Property Rights and Collective Rights Organizations , 1996 .
[3] L. Giebel. Stem cells—a hard sell to investors , 2005, Nature Biotechnology.
[4] A. Jaffe,et al. Innovation policy and the economy , 2001 .
[5] S. Filip,et al. Issues in stem cell plasticity , 2004, Journal of cellular and molecular medicine.
[6] V. Brower. Human ES cells: Can you build a business around them? , 1999, Nature Biotechnology.
[7] T. Winslow. Regenerative Medicine 2006 , 2006 .
[8] Christopher Thomas Scott,et al. The paths around stem cell intellectual property , 2006, Nature Biotechnology.
[9] Rudolf Jaenisch,et al. Nuclear reprogramming and pluripotency , 2006, Nature.
[10] D. Zilberman,et al. An intellectual property clearinghouse for agricultural biotechnology , 2001, Nature Biotechnology.
[11] J. Loring,et al. Intellectual Property and Human Embryonic Stem Cell Research , 2006, Science.
[12] Karen A. Holbrook,et al. Public Sector Collaboration for Agricultural IP Management , 2003, Science.
[13] S. Rabin. The gatekeepers of hES cell products , 2005, Nature Biotechnology.
[14] D. Zilberman,et al. The public–private structure of intellectual property ownership in agricultural biotechnology , 2003, Nature Biotechnology.
[15] M. Heller,et al. Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.